What one share of Avai Bio holds
Technologies Inc. and Trend Innovations Holding Inc.) is a technology company specializing in acquiring, creating, and developing innovative and advanced technologies utilizing artificial intelligence (AI) as well as providing a host of information technology consulting services.
Avai Bio’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.01 |
|---|---|
| Cash and investments | $0.00 |
| Book value | −$0.02 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | — | −$0.01 | — | — | — | −$0.01 |
| 2022 | — | −$0.00 | — | — | — | −$0.02 |
| 2023 | $0.01 | −$0.01 | — | — | — | −$0.02 |
| 2024 | — | −$0.02 | — | — | — | −$0.01 |
| 2025 | — | −$0.01 | — | — | — | −$0.01 |
| 2026 | — | −$0.01 | — | — | — | −$0.02 |
Common questions about Avai Bio
How much does one share of Avai Bio earn?
Over the last 12 months, Avai Bio lost $0.01 for each share.
Does Avai Bio pay a dividend?
Avai Bio didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Avai Bio’s book value per share?
Avai Bio’s book value is negative (−$0.02 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Avai Bio have?
Each share of Avai Bio has $0.00 of cash and investments, as of June 30, 2026.
Has Avai Bio bought back shares?
Avai Bio’s share count rose about 425% from 2021 to 2026. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.